Aristotle Capital Management
AMGN icon

Aristotle Capital Management’s Amgen AMGN Stock Holding History

Aristotle Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08B Sell
3,079,565
-212,999
-6% -$75.9M 2.27% 8
2025
Q4 		$1.08B Sell
3,292,564
-181,927
-5% -$57.7M 2.16% 10
2025
Q3 		$981M Sell
3,474,491
-153,136
-4% -$44.4M 1.89% 18
2025
Q2 		$1.01B Sell
3,627,627
-75,345
-2% -$21.3M 1.95% 16
2025
Q1 		$1.15B Sell
3,702,972
-185,385
-5% -$54.7M 2.3% 10
2024
Q4 		$1.01B Sell
3,888,357
-16,789
-0.4% -$4.98M 1.95% 19
2024
Q3 		$1.26B Sell
3,905,146
-20,463
-0.5% -$6.69M 2.29% 9
2024
Q2 		$1.23B Sell
3,925,609
-118,166
-3% -$34.7M 2.37% 11
2024
Q1 		$1.15B Sell
4,043,775
-110,754
-3% -$32.4M 2.13% 14
2023
Q4 		$1.2B Sell
4,154,529
-198,640
-5% -$54.1M 2.34% 10
2023
Q3 		$1.17B Sell
4,353,169
-143,898
-3% -$35.9M 2.51% 10
2023
Q2 		$998M Sell
4,497,067
-51,042
-1% -$11.8M 2.03% 22
2023
Q1 		$1.1B Sell
4,548,109
-93,872
-2% -$23M 2.3% 12
2022
Q4 		$1.22B Sell
4,641,981
-248,185
-5% -$66.5M 2.59% 7
2022
Q3 		$1.11B Sell
4,890,166
-72,128
-1% -$17.5M 2.45% 6
2022
Q2 		$1.21B Sell
4,962,294
-71,609
-1% -$17.5M 2.55% 5
2022
Q1 		$1.22B Sell
5,033,903
-22,352
-0.4% -$5.14M 2.22% 18
2021
Q4 		$1.14B Buy
5,056,255
+169,143
+3% +$35.7M 1.92% 25
2021
Q3 		$1.04B Buy
4,887,112
+41,586
+0.9% +$9.57M 1.96% 26
2021
Q2 		$1.18B Buy
4,845,526
+69,858
+1% +$17.2M 2.25% 19
2021
Q1 		$1.18B Buy
4,775,668
+379,885
+9% +$90.6M 2.42% 13
2020
Q4 		$1.01B Buy
4,395,783
+227,873
+5% +$52.5M 2.5% 10
2020
Q3 		$1.06B Buy
4,167,910
+59,300
+1% +$14.7M 3.2% 5
2020
Q2 		$969M Buy
4,108,610
+190,968
+5% +$43.6M 3.26% 6
2020
Q1 		$794M Buy
3,917,642
+102,970
+3% +$22.5M 3.35% 5
2019
Q4 		$920M Buy
3,814,672
+1,270,737
+50% +$280M 3.02% 6
2019
Q3 		$492M Sell
2,543,935
-1,404
-0.1% -$269K 2.61% 11
2019
Q2 		$469M Buy
2,545,339
+37,362
+1% +$6.69M 2.62% 10
2019
Q1 		$476M Buy
2,507,977
+87,846
+4% +$16.8M 2.83% 7
2018
Q4 		$471M Sell
2,420,131
-49,498
-2% -$9.66M 3.18% 4
2018
Q3 		$512M Buy
2,469,629
+58,174
+2% +$11.5M 2.98% 5
2018
Q2 		$445M Buy
2,411,455
+131,987
+6% +$23.3M 2.74% 8
2018
Q1 		$389M Buy
2,279,468
+86,378
+4% +$15.9M 2.61% 10
2017
Q4 		$381M Buy
2,193,090
+677,373
+45% +$120M 2.64% 10
2017
Q3 		$283M Sell
1,515,717
-5,068
-0.3% -$898K 2.19% 23
2017
Q2 		$262M Buy
1,520,785
+79,443
+6% +$12.9M 2.19% 21
2017
Q1 		$236M Buy
1,441,342
+37,721
+3% +$6.27M 2.15% 24
2016
Q4 		$205M Buy
1,403,621
+59,766
+4% +$8.99M 1.94% 28
2016
Q3 		$224M Sell
1,343,855
-27,896
-2% -$4.72M 2.33% 21
2016
Q2 		$209M Buy
1,371,751
+45,674
+3% +$7.1M 2.26% 22
2016
Q1 		$199M Buy
+1,326,077
New +$197M 2.31% 21

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aristotle Capital Management's AMGN Position: Q1 2026 in Review

Aristotle Capital Management reduced its Amgen (AMGN) stake by 6.5% in Q1 2026, selling an estimated $75.9M and leaving 3,079,565 shares worth $1.08B. The position accounts for 2.27% of the portfolio, ranked #8.

Aristotle Capital Management first reported a position in AMGN in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.26B in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Aristotle Capital Management held 3,079,565 shares of Amgen worth $1.08B as of Q1 2026.
  • Aristotle Capital Management sold 212,999 Amgen shares in Q1 2026, an estimated $75.9M.
  • Amgen made up 2.27% of Aristotle Capital Management's portfolio in Q1 2026, its #8 holding.
  • Aristotle Capital Management first reported a position in Amgen in Q1 2016 and has held it in 41 quarters since.
  • Aristotle Capital Management's Amgen position peaked at $1.26B in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aristotle Capital Management's 13F filing for Q1 2026, filed 15 May 2026.